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Nutrition appears to be an important environmental factor involved in the onset
of inflammatory bowel diseases (IBD) through yet poorly understood biological
mechanisms. Most studies focused on fat content in high caloric diets, while refined
sugars represent up to 40% of caloric intake within industrialized countries and
contribute to the growing epidemics of inflammatory diseases. Herein we aim to
better understand the impact of a high-fat-high-sucrose diet on intestinal homeostasis
in healthy conditions and the subsequent colitis risk. We investigated the early
events and the potential reversibility of high caloric diet-induced damage in mice
before experimental colitis. C57BL/6 mice were fed with a high-fat or high-fat
high-sucrose or control diet before experimental colitis. In healthy mice, a high-fat
high-sucrose diet induces a pre-IBD state characterized by gut microbiota dysbiosis
with a total depletion of bacteria belonging to Barnesiella that is associated with
subclinical endoscopic lesions. An overall down-regulation of the colonic transcriptome
converged with broadly decreased immune cell populations in the mesenteric lymph
nodes leading to the inability to respond to tissue injury. Such in-vivo effects on
microbiome and transcriptome were partially restored when returning to normal chow.
Long-term consumption of diet enriched in sucrose and fat predisposes mice to colitis.
Arnone et al. Diet & Partially Reversible Pre-IBD State
This enhanced risk is preceded by gut microbiota dysbiosis and transcriptional
reprogramming of colonic genes related to IBD. Importantly, diet-induced transcriptome
and microbiome disturbances are partially reversible after switching back to normal
chow with persistent sequelae that may contribute to IBD predisposition in the
general population.
Keywords: diet-induced, IBD-inflammatory bowel diseases, colitis, gut homeostasis, high-fat high-sucrose diet
GRAPHICAL ABSTRACT | Overview of high-fat high-sucrose-mediated predisposition to colitis and aggravating effects during established colitis. IBD, Inflammatory
Bowel Disease; LT, lymphocyte T; LB, lymphocyte B; HSP, heat shock proteins; MLN, mesenteric lymph node; ROS, reactive oxygen species; UPR, unfolded protein
response; SCFAs, Short Chain Fatty Acids.
INTRODUCTION
Inflammatory Bowel Diseases (IBD) are chronic inflammatory
diseases of the gastrointestinal tract with increasing incidence
worldwide (1). Dietary patterns in industrialized countries
are characterized by overconsumption of fats and sugars in
the total caloric availability (2), the so-called Western Diet
(WD). This consumption has increased by about 10-fold
over the last century in industrialized countries (3–5). Many
epidemiological studies concluded that WD is associated with an
increased risk of developing several human diseases, including
inflammatory conditions such as IBD (2, 6). Recent international
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recommendations expressed concerns about sugar consumption
in Westernized societies as they represent quantities with no
precedent during hominin evolution (3, 4). In both adults
and children, the World Health Organization (WHO) strongly
recommends reducing the intake of free sugars to less than 10%
of total energy intake and suggests a further reduction to below
5% (3–5).
Animal studies have shown that WD is responsible for
deleterious effects on intestinal permeability, gut microbiota,
risk of infection, and experimental colitis (7–9). While the
consequences of high-fat (HF) diets on gut microbiota dysbiosis
are well studied, few studies focused on sugar’s specific role
on intestinal homeostasis (10). A landmark study showed
that experimental type 2 diabetes drives intestinal barrier
dysfunction by transcriptional reprogramming of intestinal
epithelial cells and alteration of tight and adherens junctions
integrity (11). A high sucrose diet (enriched with 55% sucrose)
was shown to enhance the susceptibility to experimental colitis,
but experiments were performed over a very short period
(only a few days) and at a very high dose (12). More
recently, investigated sugar-induced exacerbation of colitis when
adding 10% glucose or fructose in drinking water (mimicking
sugar-sweetened beverages), dietary sugars quickly altered gut
microbial ecology (13). In agreement with these findings, rectal
insulin instillation inhibited inflammation in chemically-induced
colitis in mice (14). Although growing evidence underpins the
pro-inflammatory effect of sugars (15, 16), the long-term impact
of combined excessive intake of dietary sugar and fat due to ultra-
processed food overconsumption (enriched in added sugars)
on healthy intestine and the underlying molecular mechanisms
remain poorly described (9). Also, the potential reversibility
of high caloric diet-induced damage is unknown. Here we
investigated the effects of long-term exposure to both dietary
sugar and fat at a moderate dose (30% sucrose, 25% fat) on
the healthy intestine. We showed that combined sugar and
fat in diet induces a pre-IBD state characterized by decreased
immune cell population in the mesenteric lymph nodes (MLNs)
and associated with a gut microbiota dysbiosis, with total
depletion of bacteria belonging to Barnesiella [a genus hinted
to be protective against colitis (17)] associated with subclinical
endoscopic lesions.
Furthermore, disease risk was heightened in Germ-Free
(GF)-mice that were colonized with microbiota from high-
fat high-sucrose (HFHS)-fed mice, demonstrating that gut
microbiota dysbiosis played a critical role in the diet-induced
colitis predisposition. This pre-IBD state is also associated
with an overall down-regulation of the colonic transcriptome
characterized by differential expression of stress and autophagy-
related genes. Both transcriptome and microbiome alterations
induced by HFHS were partially reversible, with persistent
sequelae when mice were refeeding with the normal
chow diet.
Our results are in line with the beneficial effect of
reducing dietary sugars (10, 18–22). These findings support
WHO recommendations about the urgent need to reduce
sugar consumption in the general population, e.g., by limiting
processed food consumption (23).
RESULTS
High-Fat High-Sucrose Diet Causes a
Pre-inflammatory Bowel Disease State
Mice were fed with a Normal Chow diet (NC), High Fat
(HF, 25% fat) or High-Fat High-Sucrose diet (HFHS, 25% fat,
30% sucrose) for 8 weeks (Figure 1A). No differences were
observed in food and water consumption, but weight gain
were increased in HFHS-fed mice and blood glucose were
increased in both HFHS and HF-fed compared to NC-fed mice
(Figures 1B–D). Dietary intake was quite stable (2–4 g/day)
under ad libitum conditions, whereas energy intake was higher
after HFHS (4,775.7 kcal/kg) and HF (4,649 kcal/kg) than
NC (3,339 kcal/kg), as expected. Consequently, body weight
over the 8-week dietary intervention was significantly higher
in HFHS-fed mice than NC-fed mice or the HF (Figure 1B).
Blood glucose levels were measured after eight weeks of diets
and 12-h fasting (Figure 1C), and metabolic tests (oGTT and
ITT) confirmed that only HFHS diet induced prediabetes
characterized by reduced impaired glucose tolerance by insulin
resistance (Figures 1D,E).
Unexpectedly, endoscopic lesions were observed in the
colonic mucosa of HFHS-fed and HF-fed mice not treated
with Dextran-sulfate sodium (DSS) (Figure 1F), and the
endoscopic score (Figure 1G, Supplementary Table 1) was
significantly higher (1.4-fold increase; p = 0.0089) than
in NC-fed mice not treated with DSS. These endoscopic
lesions were associated with a thinning and shortening of
the colon length (-10.9mm; p = 0.012) (Figures 1L,M). At
the histological level (Figures 1H,I, Supplementary Table 2),
some HFHS-fed animals showed a chronic inflammatory cell
infiltrate (lymphoplasmacytic, Supplementary Table 3), with no
significant increase in the global score (Figure 1I).
Then we used DSS colitis as a control and we confirmed that
clinical manifestations of colitis appeared earlier in HFHS-fed
mice (day 3) and that the colitis was more severe, as reflected
by decreased body weight (Supplementary Figure 1A) and
the higher Disease Activity Index (DAI) in the HFHS DSS+
group compared with NC DSS+ animals (3.8 vs. 2.7 at day
10, respectively; p < 0.0001) (Supplementary Figure 1B).
Likewise, the endoscopic score indicated a severe colonic
inflammation (Supplementary Figures C,D) that was also
confirmed histologically (Supplementary Figures 1E,F,
Supplementary Table 1). This was further supported
by the thinning and shortening of the colon length
(Supplementary Figures 1G,H). In agreement with these
findings, an enlarged spleen was observed in either HFHS
DSS+ mice (about larger 3-fold maximum size compared to NC
DSS+; p = 0.0001) (Supplementary Figures 1K,L) or HFHS
DSS− mice (1.5-fold on average compared to NC DSS−; p
= 0.11; Figures 1J,K). In contrast, no significant decrease of
colon length was observed in HF-fed mice, even with colitis
(Supplementary Figures 1I,J). On day 5 of DSS-treatment,
intestinal permeability was measured by FITC-Dextran, showing
that only HFHS-fed mice treated with DSS had increased
permeability compared to both NC or HF DSS+ group
(Supplementary Figure 1D). Furthermore, HFHS increased
Frontiers in Nutrition | www.frontiersin.org 3 November 2021 | Volume 8 | Article 758518
Arnone et al. Diet & Partially Reversible Pre-IBD State
FIGURE 1 | Additive effects of sucrose and fat in healthy mice. (A) Experimental design. Mice were fed 8 weeks with normal chow diet (NC) or High-Fat (HF) diet or
High-Fat High-Sucrose (HFHS). (B) Body weight of HSHF-fed mice (N = 40) was higher than HF-fed mice (N = 10) or NC-fed mice (N = 36). (C) Fasting blood
glucose levels in HFHS, HF and NC-fed mice (N = 10 /group). (D) Insulin tolerance test (ITT) after 8 weeks of diet (0.75 U/kg insulin, ip). (E) Oral glucose tolerance test
(oGGT) after 8 weeks of diet (2 g/kg per os) for HFHS, HF and NC-fed mice (N = 5/group). (F) Representative colonoscopy images (G) Ulcerative colitis endoscopic
index of severity (UCEIS) (H) Representative sections of colon, arrows show epithelial dystrophies. Scale bars, 0.10mm. (I) Histological scores. (J) Gross pictures of
spleens, scale bars: 10mm. (K) Spleen weight to body weight ratio. (L) Gross pictures of colons. Scale bars, 10mm. (M) Colon lengths. Data are given as means +/-
SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by ANOVA (two-way for B, D and E) for parametric data or Kruskal-Wallis if not.
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early mortality during DSS-colitis whereas HF-fed mice have
similar mortality to NC-fed (30% of HFHS-fed mice from the
3rd day; p = 0.0066 vs. 20% of NC or HF-fed mice died after 7
days; Supplementary Figure 1C).
Altogether, these data showed that sucrose added to fat (rather
than fat alone) aggravates the severity of DSS-induced colitis
clinically, endoscopically, and histologically. Under physiological
conditions, such diet induces a pre-IBD state characterized by
endoscopic lesions, reduced colon length, and inflammatory cell
infiltration in the colonic mucosa.
Specific Effects of Sucrose on the
Intestinal and Systemic Immune
Homeostasis of Healthy Mice
To determine the respective impact of fat vs. sugar on the
immune system, we first performed cytometry analysis on the
spleen and MLNs of mice. Interestingly, we observed that
all studied immune cells population were decreased in MLNs
of HFHS-fed mice, whereas they were increased in HF-fed
mice compared to NC-fed mice (Figures 2A–F). Specifically,
numbers of leukocytes, myeloid cells, and lymphocytes, including
B and T cells, were decreased in HFHS-fed mice, whereas
they were increased in HF-fed mice compared to NC-fed mice
(Figures 2A–F). However, these cells were not significantly
disturbed in the spleen (Figures 2G–K) except myeloid cells
representing 8.5% of leukocytes in HFHS-fed mice, while
they only represented 2.1% in NC-fed mice (Figure 2H,
Supplementary Figure 2A). Likewise, T-cells represented 25.9%
of lymphocytes in HFHS-fed mice vs. 31.9% in control animals
(Figure 2J, Supplementary Figure 2A). Among the lymphocytes
in the MLNs, while NK cells amounted to an average of
18.7% CD45+CD3- cells in NC-fed mice, they expanded
to 24.6% in HFHS-fed mice and 45.8% in HFD-fed mice
(Supplementary Figure 2A). Likewise, T-cell subpopulations,
including CD4+ and CD8+ cells, were strongly decreased
in HFHS-fed mice MLNs but not significantly in the spleen,
compared to control animals (Figures 2L–O). Significantly, Th17
cells were strongly decreased inMLNs of HFHS-mice and slightly
increased in the spleen than NC-fed animals (Figures 2P,U).
We next focused on HFHS-fed mice, and to further dissect
the local and systemic immune response, we measured cytokine
levels in plasma and colonic tissues. As expected, cytokines levels
in plasma (Supplementary Figures 2B–D) were significantly
increased in DSS-treated mice fed with NC compared to
untreated animals (IL-1β: +25.39 pg/mL, p = 0.0212; IL-
6: +77.34 pg/mL, p = 0.0005; TNF-α: +108.8 pg/mL, p =
0.0351). Unexpectedly, these cytokines were not increased in
plasma of colitic HFHS-fed mice compared to not-treated
HFHS-fed animals excepted for IL-6 (+75.56 pg/mL, p =
0.0002; Supplementary Figure 2C). Then we measured levels
of several chemokines in the colonic tissues of HFHS-fed
mice. In contrast to plasma, chemokine levels were higher in
colonic tissues of HFHS-fed colitic mice compared to DSS-
untreated animals (RANTES:+295.0 pg/mL, p= 0.015; Eotaxins:
+760.7 pg/mL, p = 0.037 and KC: +55.67 pg/mL, p = 0.026;
Supplementary Figures 2E–G).
In summary, these findings indicate that fat and sugar
induced similar intestinal lesions but have a differential
effect on the immune system. In contrast to HF that
increased immune cells, sucrose enrichment decreases the
number of immune cells in both MLNs and the spleen.
While HFHS causes impaired systemic cytokine response,
chemokines recruitment is maintained in the colon of
these animals.
High-Fat High-Sucrose Diet Induces an
Overall Down-Regulation of the Colonic
Transcriptome of Healthy Mice
To better understand how HFHS may predispose to disease
risk in later life, transcriptomic analyses were performed
on colonic tissues of DSS-untreated mice. Interestingly, in
healthy mice, HFHS caused a strong gene down-regulation
compared to NC-fed mice (Figure 3A). Statistical analyses
identified 154 differentially expressed genes, 86% (132)
being under-expressed in HFHS-fed mice (FDR < 0.05;
fold change > 30%) (Supplementary Dataset 1). These genes
were predominantly involved in response to diverse cellular
stresses such as HSF1-mediated heat-shock, external stimuli,
unfolded protein stress via HSP90 chaperone complex, and to a
lesser extent in the regulation of transcription and translation,
as well as in Class I MHC mediated antigen processing
and presentation (Figure 3B). Functional annotations with
OpenTargets confirmed an association between the HFHS
gene signature and nutritional and metabolic diseases such as
diabetes (62 targets), abnormalities of the immune system (75
targets), and infectious diseases (104 targets). Interestingly,
they also unraveled an association between HFHS and “colitis”
(37 targets) or IBD (47 targets) despite the absence of DSS
treatment, which is consistent with the pre-IBD state observed
at the endoscopic and histologic levels (all p-values < 0.001)
(Supplementary Table 4). Among the upregulated genes
in HFHS-fed mice, we observed Shisa5, which encodes an
endoplasmic reticulum protein involved in the apoptotic process
(+1.5-fold; FDR = 0.029) and Slamf7, involved in cell-cell
interactions by modulating the activation and differentiation
of a wide variety of immune cells and in response to anti-TNF
therapy in IBD (24, 25) (+1.6-fold; FDR = 0.046). Conversely,
Rgs1, which encodes for a protein inhibiting B cells chemotaxis,
was strongly under-expressed (−2.22-fold; FDR = 0.033) in
HFHS-fed mice (Figure 3C), while being overexpressed in active
IBD (26). Stress-related genes were under-expressed in HFHS-
fed mice: Hsph1, which encodes a member of the heat shock
protein 70 family (−3-fold; FDR = 0.036), Hspa8 (−2.5-fold;
FDR = 0.024), Hspa5 (−2.1-fold; FDR = 0.013), and Rb1cc,
indirectly implicated in autophagy via Atg16L1 interaction
(−1.9-fold; FDR = 0.025), all coding for heat shock proteins
(HSP) involved in autophagy and endoplasmic reticulum stress.
Moreover, chaperones associated with these HSP were also
downregulated in HFHS-fed mice: Dnajb1 (−1.8-fold; FDR =
0.0002) and Dnaja1 (−2.1-fold; FDR = 0.0005), both implicated
in the regulation of heat shock proteins, or Chordc1, encoding a
protein proposed to act as co-chaperone for HSP90 (−2.2-fold;
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FIGURE 2 | Sucrose repressed immune cell levels in mesenteric lymph nodes and spleen. (A) Representative flow cytometry recording mesenteric lymph nodes
(MLNs) and spleen. (B–U) Relative abundance of indicated immune cell populations MLNs or spleen for mice fed with normal chow diet (NC, N = 5), high-fat diet (HF,
N = 5), or high-fat high-sucrose (HFHS, N = 5). Means +/- SEM are plotted. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by ANOVA for parametric data or
Kruskal-Wallis if not.
Frontiers in Nutrition | www.frontiersin.org 6 November 2021 | Volume 8 | Article 758518
Arnone et al. Diet & Partially Reversible Pre-IBD State
FIGURE 3 | High-fat high-sucrose diet triggers multiple cellular stress responses on the colonic transcriptome. (A) Volcano plot and (B) Top Reactome pathways of
dysregulated genes for HFHS-fed mice (N = 5) vs. NC-fed (N = 5). Statistical analyses identified 154 differentially expressed genes, 86% (132) being under-expressed
in HFHS-fed compared to NC-fed mice (FDR < 0.05; fold change > 30%). (C, D) Top dysregulated genes in mice fed a HFHS diet compared with NC diet. Mean
expression values (log2) are plotted with standard deviations for up- and down-regulated genes. FDR *≤ 0.05, ** < 0.01, *** < 0.001.
FDR = 0.003) and Ahsa2, a pseudogene proposed as an HSP90
stimulating co-chaperone (−2.2-fold; FDR= 0.003) (Figure 3D).
Overall, HFHS modulated several molecular pathways involved
in cellular stress-related pathways in the healthy intestine
of mice.
High-Fat High-Sucrose Induces Dramatic
Changes in Gut Microbiota and Its Derived
Metabolites in Healthy Mice
Prior to colitis, we investigated the impact of diet on the fecal
microbiota by comparing its diversity and composition before
starting the different diets (baseline or B) and after eight weeks
of dietary intervention (day zero or D0). We observed that
HFHS-fed mice had a lower α-diversity at baseline for the Chao
(Figure 4A) and Shannon (Supplementary Figure 3A) indices
because of the acclimatization period (diet was not the same
throughout the acclimatization period and the experiment). To
evaluate the diet’s impact beyond the initial founder effect, we
calculated a fold change of the α-diversity indices at D0 relative
to baseline. We observed no significant difference between
each diet group’s fold changes, both for Chao (Figure 4B) and
Shannon indices (Supplementary Figure 3B). These results
indicated that the dietary intervention did not strongly influence
the α-diversity of the intestinal microbiota. Considering β-
diversity, we observed a strong association with the diet for each
time point (Supplementary Table 5), and for both Bray-Curtis
and Jaccard indices (Figure 4C, Supplementary Figure 3C),
with explained variance >42%. However, within diet groups, a
significant difference between time points was observed only for
HFHS-fed mice, with explained variance >25% for Jaccard index
and >71% for Bray-Curtis index (Supplementary Table 5).
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FIGURE 4 | High-fat high-sucrose diet induces gut microbiota dysbiosis. (A) α-diversity measured by Chao index at baseline B for mice fed with normal chow (NC, N
= 10) vs. high-fat high-sucrose diet (HFHS, N = 9). (B) Evolution of species richness measured by a fold change of Chao index at D0 relative to B. (C) PCoA of
Bray-Curtis β-diversity index showing no NC-fed vs. HFHS-fed mice, at B and at D0. (D–H) Fold change of indicator OTU’s abundances at D0 relative to B. (I, J) Short
Chain Fatty Acids concentrations in µmol/g of caecal content or feces of NC-fed or HFHS-fed mice. Means +/– SEM are plotted. *p < 0.05, **p < 0.01 by ANOVA for
parametric data or Kruskal-Wallis if not when more than 2 groups are compared, Mann-Whitney test or t-test for 2 groups comparison.
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These results indicate that despite the initial difference between
animal groups, the HFHS-fed mice had an essential change in
the composition of their fecal microbiota, strongly affecting
core abundant bacteria, and to a lesser extent, the prevalence
of less abundant species. Consistently, we identified five
Operational Taxonomic Units (OTUs) indicators for diet,
with OTUs defined as follows: i) abundance/prevalence is
significantly associated with diet at D0 but not at baseline, and
ii) fold change between D0 and B is significantly associated
with diet (Supplementary Figure 7). Precisely, two OTUs
belonging to the order Clostridiales (Otu036, Otu044) showed
an apparent decrease in their relative abundance in HFHS-fed
mice while remaining at a similar abundance in NC-fed mice
(Figures 4D,E, Supplementary Figure 3). Two OTUs belonging
to the family Lachnospiraceae (Otu052, Otu146) showed a
strong increase of their relative abundance and prevalence
in HFHS-fed mice (Figures 4F,G, Supplementary Figure 3,
Supplementary Table 5). One OTU belonging to the genus
Barnesiella (OTU194) was not found at baseline but was
ubiquitous at D0 in NC-fed mice, while present in only
one HFHS-fed animal, in lower abundance (Figure 4H,
Supplementary Figures 3P–U). These results suggest that HFHS
can significantly impact individual bacteria, most of them
belonging to Firmicutes, known to produce short-chain fatty
acids (SCFAs) (27) (Supplementary Figure 7). These biomarkers
represent together more than 90% of the OTUs, while Firmicutes
represent∼50% of the entire community, indicating that bacteria
belonging to this phylum might be significantly impacted by the
dietary intervention.
We next measured SCFAs concentration in caecal contents
and feces of mice, and showed that microbial changes
induced by HFHS were followed by a significant decrease
in caecal and fecal SCFAs concentrations (Figures 4I,J).
Indeed, caecal propionate and butyrate concentrations were
decreased, whereas isovalerate concentration increased
in HFHS-fed mice compared to control animals (p <
0,05) (Figure 4I). Likewise, fecal acetate, propionate,
and especially butyrate concentrations were profoundly
reduced in HFHS-fed mice compared to control animals
(p < 0,05) (Figure 4J).
To highlight the role of the gut microbiota in this
experimental context, we performed fecal microbiota
transplantation (FMT) in germ-free (GF) mice before
inducing DSS-colitis (Supplementary Figure 4A). Despite
the initial difference in GF-mice bodyweight before FMT,
those who received microbiota from HFHS-fed mice recovered
their initial weight after transplantation, contrary to NC-
fed mice transplanted (Supplementary Figure 4B). Then,
GF-mice that received microbiota from HFHS or HF-fed
mice developed higher colitis than mice transplanted with
fecal microbiota from control mice, as illustrated by higher
bodyweight loss (Supplementary Figure 4D), survival rate
(Supplementary Figure 4C). Importantly, at day 8, GF-mice
that received HFHS-fed microbiota had an increased DAI
(Supplementary Figure 4E).
Incomplete Recovery of High-Fat
High-Sucrose-Induced Damage Upon
Cessation of Overconsumption
To assess whether the changes induced by HFHS could be
restored, we analyzed the gut microbiome and transcriptome
of mice fed eight weeks with NC after eight weeks of HFHS
(Figure 5A). Colonic transcriptome reprogramming detected
in HFHS-fed mice was only partially reversible in HFHS+NC-
fed mice (Figure 5B). Detailed results are described in
Supplementary Material. Briefly, further hierarchical clustering
identified six dysregulated signatures in HFHS+NC-fed mice,
predominantly involved in unfolded protein response (UPR),
autophagy, heat shock protein response, and metabolic pathways
that play a crucial role in intestinal homeostasis (Figure 5B,
Supplementary Table 6). Among upregulated genes in HFHS,
many genes involved in p53/TP53-dependent apoptosis returned
to regular expression levels (as observed in NC-fed mice) after
switching diet while many HSP-related genes were down-
regulated in HFHS-fed mice failed to recover their baseline
expression in HFHS+NC-fed mice (Figures 5C–E). Regarding
disease-associated targets, genes from clusters 2 and 5 were
still associated with immune system diseases (75 targets) and
gastrointestinal diseases (60 targets) including IBD (27 targets),
ulcerative colitis (20 targets), Crohn’s disease (15), “colitis” (22
targets), and digestive system infectious diseases (44 targets) (all
p-values < 0.09; Supplementary Table 7).
Similar observations were made on the composition
of the gut microbiota. Detailed results are described in
Supplementary Material. Briefly, NC-fed mice did not vary
in α-diversity, while HFHS-fed mice had a lower diversity
at D0 compared to baseline, and the HFHS+NC-fed group
had a higher diversity at D0 compared to baseline only for
the Chao index (Figures 6A,B). Regarding β-diversity, all
groups were significantly different from each other at D0, but
the HFHS-fed mice showed the highest distance to the other
groups (Figure 6C). Among the indicators identified in the
eight-week protocol, Otu036, Otu052, and Otu194 showed an
interesting pattern, where the HFHS+NC-fed mice were in
line with NC-fed mice and opposed to HFHS-fed mice, despite
an initial difference according to diet group (Figures 6D–I,
Supplementary Figure 7).
These results indicate that (i) HFHS has a consistent effect
on microbial composition, given that four out of five biomarkers
showed a similar pattern in both protocols, and (ii) a return toNC
diet after eight weeks of HFHS can restore microbial abundances
for four out of five diet-specific species identified in the eight-
week protocol. Consistently, colitis severity was improved in
HFHS-fed mice (Supplementary Figure 6).
Taken together, these results suggest that the long-
term harmful effects of HFHS on gut microbiota and
transcriptome can be partially corrected even after the return
to a normal chow: some transcriptomic imprints lasted,
and some effects persisted after exposure to HFHS on the
gut microbiota.
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FIGURE 5 | Partially reversible effects of high-fat high-sucrose diet on the colonic transcriptome. (A) Experimental design. Mice were fed with a normal chow diet (NC,
N = 10) or a high-fat high-sucrose diet (HFHS, N = 10) for 16 weeks or 8 weeks and then switched back to NC for 8 weeks (HFHS+NC, N = 10). (B) Hierarchical
clustering heatmap of the most variable genes in NC vs. HFHS vs. HFHS+NC fed mice. (C–E) Expression levels of relevant genes in clusters C1 to C6 for groups of
mice fed with NC, HFHS or HFHS+NC, mean expression values (log2) are plotted with standard deviations for up- and down-regulated genes. FDR *≤ 0.05, ** <
0.01, *** < 0.001, **** < 0.001.
Frontiers in Nutrition | www.frontiersin.org 10 November 2021 | Volume 8 | Article 758518
Arnone et al. Diet & Partially Reversible Pre-IBD State
FIGURE 6 | Incomplete recovery of microbiota dysbiosis. (A) α-diversity measured by Chao index of NC-fed, HFHS-fed, or HFHS+NC-fed (N = 10 per group) mice at
baseline B. (B) Evolution of species richness measured by a fold change of Chao index at day zero (D0) relative to B. (C) Principal coordinate analysis (PCoA) of
Jaccard β-diversity index showing NC-fed, HFHS-fed, or HFHS+NC-fed mice, at B and D0. (D–H) Fold change of abundances at D0 relative to B of the five
operational taxonomic units (OTUs) identified as an indicator for diet in the 8-weeks experiment (see Supplementary Figure 6 and EV8). (I) Prevalence of indicated
OTUs at D0 after 16 weeks of NC, HFHS, or NC following HFHS.
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DISCUSSION
Dietary patterns are important environmental triggers in IBD
(6, 28). Overconsumption of dietary sugar has been linked to
a rise of several non-communicable diseases (2–5). Recently,
hyperglycemia was shown to disrupt the intestinal barrier and
promote risk for enteric infections (11), while a high-sugar diet
(at very high dose 55% sucrose) was reported to enhance the
susceptibility to colitis by depletion of SCFAs after only two
days of dietary intervention (12). Likewise, short-term intake
(seven days) of a low dose of sugar (10% glucose or fructose
in drinking water) did not trigger inflammatory responses in a
healthy gut but markedly altered gut microbiota composition,
leading to a predisposition to colitis (13). Here, we first confirmed
that moderate doses of sucrose and fat (30% sucrose 25%
fat) aggravates experimental colitis (12, 13). The DSS-colitis
model induced profound intestinal damage and immunological
disruption (29). Despite the growing interest of the scientific
and medical community, the direct effects of long-term high-fat-
high-sugar intake on healthy individuals’ gut and the potential
reversibility of those effects remain poorly described.
Therefore, we explored the long-term impact of additive
effects of fat and sugar on intestinal homeostasis and focused
on the specific effects of such diet on healthy mice intestine.
Thaiss et al. demonstrated that glucose induced barrier
alterations in vitro and increased permeability in diabetic
mice (11). Unexpectedly, we showed that endoscopic lesions
were observed in long-term HFHS-fed mice not treated with
DSS (Figures 1F,G), whereas Khan et al. reported that short-
term exposure to sugar minimally affected gut physiology
(13). In our model, we can explain the lack of impact
of HFHS on gut permeability (assessed by FITC-dextran,
Supplementary Figure 1D) by the moderate hyperglycemia in
mice (blood glucose average 2.5 g/L (Figure 1C); which is in
agreement with glycemia observed in overweight C57BL/6 mice)
while in diabetic models blood glucose exceeds 4.5 g/L (30).
To clarify the contribution of fats in our model, we used a
HF diet with moderate dose. Indeed, HF is known to promote
inflammation and exacerbates colitis severity at a very high dose
(60% kcal from fats) (31). In our study, fats represented 25%
of the regimen and, as expected, did not significantly influence
the bodyweight or insulin/glucose sensitivity (Figures 1D,E)
(32). More importantly, a 25%-HF did not influence colitis
severity in our model so we can conclude that it’s the addition
of 30% sucrose in the HFHS diet that is responsible for the
effects observed.
Overweight-induced hyperglycemia has been shown to
impair immune defenses, as illustrated by diabetes-induced
immunodepression that increases susceptibility to infections (33,
34). The relationships between hyperglycemia and pathological
inflammation have been extensively studied (35). Our flow
cytometry data showed (Figure 2, Supplementary Figure 2) a
differential effect of fat vs. sugar on immune cell populations
of MLNs and spleen. While HF increased the whole immune
cell population in MLNs of mice, HFHS caused the opposite
effect and especially strongly decreased the number of T
cells in both spleen and MLNs of mice. Consistently, we
observed a broadly depressed cytokine profile of HFHS-fed mice
(Supplementary Figure 2), which may explain the susceptibility
to enteric infection observed in hyperglycemic mice (8, 11). It
would have been intersting to determine cytokine profile in HF-
fed mice compared to HFHS-mice it is one of the limitations of
our study. However, it can be assumed from other studies that
HF diet increased pro-inflammatory cytokines secretion (36).
Considering that such impaired immune defenses are a hallmark
of IBD, this strengthens the link between sugar homeostasis and
intestinal inflammation (37).
Furthermore, enlarged spleen and increased splenic myeloid
and Th17 cells were observed in HFHS-fed mice, whereas they
were decreased in MLNs, suggesting that immune cells may
be mobilized on the inflammation site, i.e., the colon, similar
to what has been observed with HF-induced colonic dysbiosis
(38). It would have been necessary to explore this hypothesis by
performing IHC stainings of flow cytometry on colons samples,
it is one of the limitations of our study. Consistently, at the
histological level, we observed immune cell infiltration in the
colon of HFHS-fed mice (Supplementary Tables 2, 3). A recent
study underpins a pro-inflammatory role for dietary sugar in
LPS-stimulated mononuclear phagocytes, which occurs at the
expense of metabolic flexibility (15), but further studies are
needed to understand how metabolic reprogramming of several
immune cell types can influence the functionality of immune
cells (39).
Transcriptomics changes induced by sugar overconsumption
in a healthy intestine were unknown. Our transcriptomic results
showed that HFHS might predispose intestinal mucosa to IBD
state. An overall down-regulation of the transcriptome was
observed in HFHS-fed mice (Figure 3). Functional annotations
reported in HFHS-fed mice not subjected to DSS treatment were
significantly associated with IBD (Crohn’s disease, ulcerative
colitis, and “colitis”), confirming the observed endoscopic pre-
IBD state. Immune reactivity to heat-shock-protein (HSP)
resulted from inflammation in various disease animal and human
inflammatory conditions such as diabetes (40). This is in line with
previous reports looking at small bowel in a cancer mice model
(41). In the colonic mucosa of HFHS-fed mice, Hsph1, Hspa8,
and Hspa5, involved in autophagy and endoplasmic reticulum
stress, were strongly under-expressed. The same observation
was made for some chaperones implicated in HSP regulation,
such as Dnajb1, Chordc1, and Ahsa2. However, among the
limitations of our study, it would have been interesting to
further explored (and to confirmed transcriptional observations)
the potential mechanism for increased susceptibility to DSS-
induced inflammation in HFHS-fed mice by IHC stainings
and/or Western-blotting analysis on colonic samples.
Particularly, many of these HSP are ubiquitous and involved
in cellular homeostasis maintenance under stress conditions (e.g.,
ATP hydrolysis, protein folding) (40). Importantly, we explored
the reversibility of HFHS-induced alterations by switching mice
back to NC diet after eight weeks of HFHS (Figure 5). We
showed that only a small part of the transcriptome could be
restored, leaving an entire pan of the program dysregulated.
This could predispose or lower the tolerance of the intestinal
mucosa to injury. For example, concerning HSP-related genes,
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only 3 genes (Ccng1, Hspa8, and C1galt1) recovered the same
expression level in HFHS+NC-fed mice (i.e., the expression
level of NC-fed mice) and were decreased in HFHS-fed mice
(Figure 5). Furthermore, small gene clusters were enriched with
CEBPB targets (CCAAT/enhancer-binding proteins, essential
for adipogenesis and gluconeogenesis and highly expressed in
adipose tissue) in HFHS-fed mice, which regulate the main
functions of the inflammatory response, intrinsically linking
the stress response to carbohydrate homeostasis (42). Since
HFHS decreases energy needs, the increase in endoplasmic
reticulum stress should be viewed as a way to counterbalance
the downregulation of these transcription factors related to HSP
(43), further contributing to the pre-IBD state. In addition to the
diet-induced damage and disturbances described in this study,
we observed the dysregulation of carcinogenesis-related genes in
the colonic mucosa of HFHS-fed mice. This observation aligns
with increasing evidence that dietary sugars are involved in
colorectal carcinogenesis, both in humans and animals (16, 37,
44). However, this was outside the scope of our study, and the
links between HFHS, colitis, and colorectal cancer will require
further investigation.
Finally, given the growing body of evidence linking microbial
dysbiosis to IBD (45), we investigated the extent to whether
intestinal bacteria may contribute to the effects described here.
A previous report using short-time exposure to sugar (12)
suggested that long-term diet exposure does not condition the
DSS-related changes in α-diversity. However, we could observe
a great difference in community composition between the diet
groups (Figure 4). As expected, dietary intervention caused
significant changes in animals’ microbiota composition, both
qualitatively and quantitatively (7, 46, 47), findings which were
further supported by FMT experiments. In line with previous
reports (12, 13), our results indicate that HFHS strongly impacts
some bacterial taxa, most of them belonging to Firmicutes that
are known to produce SCFAs and may enhance the epithelial
permeability in response to high caloric diet (48, 49). This
phylum is composed of gram-positive bacteria and includes the
gut commensal Clostridia, which was shown to be a key player of
intestinal homeostasis (50). Some members of the Clostridiales
family were present in lower abundance in HFHS-fed mice
not subjected to DSS-treatment while some Lachnospiraceae
species increased, changes that were not observed with short-
term exposure to sucrose (12). In addition to previous studies
(12, 13) showing that a few days of sugar decreased only
fecal and caecal acetate concentrations, we showed that 8-week
overconsumption of sugar profoundly decreased both acetate,
propionate, and butyrate concentrations. Our observations
indicate that long-term overconsumption of sugar has a strong
impact on intestinal microflora and their metabolites. SCFAs
are known to play a key role in health maintenance by
promoting both lipid, glucose, and immune homeostasis (51),
so their decrease may also contribute to the observed pre-
IBD state.
Even if additional work is needed to demonstrate that this may
contribute to the pre-IBD state, it is noteworthy that the depletion
of bacteria belonging to Barnesiella (Otu194) was observed in
HFHS-fed mice while it was ubiquitously present in control
animals (i.e., NC-fed mice). This may contribute both to the pre-
IBD state, and the severity of DSS-induced colitis observed in
this study. Indeed, given that an increase of Barnesiella spp. after
oligosaccharide treatment was shown to decrease susceptibility
to DSS-induced colitis in mice (17). Of interest, returning to
the NC diet after 8-weeks of HFHS does not allow full recovery
of this bacterial species (Figure 6). Similarly, the increase in
Lachnospiraceae was only partially reversible, as Otu146 was
absent in NC-fed mice but remained high in HFHS+NC-fed
mice. Previous experiments (12, 13) demonstrated that sucrose
induces very rapid changes in the microbiota composition. Our
findings suggest that these modifications are persistent and
difficult to reverse after long-term overconsumption of fat and
sugar, even after returning to the NC diet for several weeks.
Therefore, long-term sucrose and fat overconsumption induce
some irreversible intestinal damage.
In summary, long-term overconsumption of fat and sugar
induces a pre-IBD state under healthy conditions. This
infraclinical state is characterized by decreased immune cell
populations in MLNs and dysregulation of stress-related genes in
the colonic mucosa leading to (i) gut microbiota dysbiosis, (ii)
spontaneous endoscopic lesions, and (iii) global transcriptome
alterations that were partially reversible. Overall, our results
support observations in IBD patients that suggest a beneficial
effect of reduced sugar consumption (10, 18, 22, 52). However,
to ensure that the results observed in this study are translaTable
to humans, intervention trials need to be initiated. In this regard,
the increased consumption of sugars in the general population




Male C57BL/6J mice were purchased from Janvier Labs (Le
Genest-Saint-Isle, France). All procedures were performed
following guidelines established by the European Convention
for the protection of Laboratory Animals (54) and with a
project approval (authorization N◦APAFIS#16630) delivered by
the French ministry of research. The animals were maintained
on a strict 12-h light-dark cycle and were housed at 22–
23◦C, in cages containing a maximum of 5 animals, with ad
libitum access to food and water. All animal experiments were
repeated at least two times on two separate occasions. Before
dietary interventions, mice were randomized to ensure that no
incidental pre-diet differences in body weight existed between
the different groups. Mice were fed with a High-fat high-sucrose
Diet (HFHS; U8960 v5, Safe Diets, Augy, France), High Fat diet
(HF U8960 v143, Safe Diets, Augy, France), or Normal Chow
diet (NC; A04, Safe Diets, Augy, France) for 8 or 16 weeks
(Figure 1A).
Induction of Colitis
For each dietary regimen (NC, HFHS, or HF), half of the animals
were treated with DSS to induce colitis after eight weeks of diet
(Figure 1A). Mice were continued on the same diet during colitis,
induced by administration of 3% dextran sulfate sodium (DSS,
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molecular weight 36 000–50 000, MP Biomedicals, Strasbourg,
France) dissolved in drinking water for five days. DSS solution
was replaced thereafter by normal drinking water for another
five days as previously described (55). Mice were sacrificed
on the 10th day or upon reached the endpoint (i. e. > 20%
weight loss).
Fecal Microbiota Transplantation
Germ-Free (GF) C57BL/6J mice were housed at gnotobiotic
facilities at the Hannover Medical School (Hannover, Germany),
and Fecal Microbiota Transplantation (FMT) experiments
were performed at Technical University Dresden (Dresden,
Germany). For microbial reconstitution of GF mice, 8-week-
old GF C57BL/6J mice received fecal material obtained from
individually WT C57BL/6J HFHS-fed or HF-fed or NC-fed
mice. Stool pellets were freshly dissolved in PBS with 0.05%
L-cysteine hydrochloride (Sigma-Aldrich; 4 pellets per 5ml of
PBS), and mice received 100 µl solution by gavage. After
one week, colitis was induced by administration of 2% DSS
dissolved in drinking water for five days. DSS solution was
replaced thereafter by normal drinking water for another
three days.
Collection of Samples
For gut microbiota analysis, fresh stool samples from isolated
mice were collected in tubes, immediately frozen in liquid
nitrogen upon collection, and stored at −80◦C until DNA
isolation. Blood was collected by submandibular bleeding (56) in
heparinized tubes (Microtainer R© BD medical, Franklin Lakes,
NJ), and the plasma was obtained by centrifugation at 2000 xg
> 3min at room temperature. The entire colon was removed
from the caecum to the anus. The colon length was measured,
then washed with phosphate-buffered saline PBS 1X to remove
the remaining content. The spleen was removed and weighed as
previously described (57). Samples from the colon were taken,
divided into 0.5 cm long pieces, snap-frozen in liquid nitrogen,
and stored at−80◦C until use.
In vivo Metabolic Tests
Metabolic tests were performed with 10 mice per group
using standard procedures (58). Oral glucose tolerance tests
(OGTT) were performed with mice fasted overnight for 6 h.
Blood glucose concentrations were determined before and after
administering glucose solution orally via gavage (2g glucose/kg).
Blood glucose levels were determined at defined post-gavage
time points by analyzing blood obtained from the tail vein with
a portable glucometer (Glucometer OneTouch R© Verio Reflect,
LifeScan Europe GmbH, Zug, Switzerland). For insulin tolerance
tests (ITT), mice were fasted for 3 h and then injected with
human insulin (0.75 U/kg i.p.; NovoRapid R©, NovoNordisk A/S,
Denmark). Blood glucose levels were monitored as described for
the OGTT assay.
Measurement of the Colonic Epithelial
Barrier Permeability by FITC-Dextran
On the day of the assay (day 5 of DSS-treatment), 4 kDa
fluorescein isothiocyanate (FITC)-dextran (Sigma-Aldrich, St.
Louis, MO) was dissolved in PBS 1X to obtain a stock
solution of 80 mg/mL. Mice fasted for 4 h before gavage with
60 mg/100g. Blood was collected 3 h following gavage on
heparinized tubes (Microtainer R© BD medical, Franklin Lakes,
NJ). FITC-Dextran was quantified in plasma by fluorescence (γ
Ex/Em 485 nm/535 nm, ID3, Molecular devices) as previously
described (11).
Assessment of Disease Activity Index
Mice were daily weighed and evaluated for clinical symptoms.
The Disease Activity Index (DAI) was determined on a scale from
0 to 4 and calculated as the mean of three individual subscores
(body weight loss, stool consistency, and blood in the stool) as
previously described (59).
Endoscopic Assessment and Scoring
Coloscopy was performed on the last day of the study (day 10),
just before the mice were sacrificed. Mice were anesthetized by
isoflurane inhalation. Distal colon and rectum were examined
using a rigid Storz Hopkins II mini-endoscope (Storz, Tuttlingen,
Germany) coupled to a basic Coloview system (with a xenon 175
light source and an Endovision SLB Telecam; Storz). All images
were displayed on a computer monitor and recorded with video
capture software (StudioMovie Board Plus from Pinnacle, Menlo
Park, CA). Three independent trained-readers performed a blind
determination of endoscopic scores. Ulcerative colitis endoscopic
index of severity (UCEIS) was calculated as the sum of three
subscores (vascular pattern, bleeding, and erosions/ulcers), as
previously described (60). The final grade was defined as the
mean of the three independent assessments.
Histological Assessment and Scoring
Colon samples were extensively washed and fixed with
4% paraformaldehyde for 24 h under agitation. Samples
were washed, paraffin-embedded, and sectioned. Colitis
was histologically assessed on 5µm sections stained with
hematoxylin-eosin-saffron (HES) stain. The histological
colitis score was calculated blindly by expert pathologists,
as previously described (61). Briefly, disease scoring based
on six histological features: acute inflammatory cell infiltrate
(polymorphonuclear cells in the lamina propria), crypt
abscesses, mucin depletion, surface epithelial integrity, chronic
inflammatory cell infiltrate (round cells in the lamina propria),
and crypt architectural irregularities. Each feature was graded
on a 4-point scale corresponding to none, mild, moderate, or
severe. The final grade was defined as the mean of the two
independent assessments.
Flow Cytometry
Mesenteric lymph nodes and spleen samples were washed and
conserved in complete RPMI (10 % FCS). Samples were first
grinded on a nylon mesh (40µm cell strainer, Greiner), and
large debris was removed. Cell suspensions were filtered through
a 70µm mesh (Miltenyi Biotec) and centrifuged at 4 ◦C,
600 xg, for 5min. Cell suspensions were then washed and
resuspended in phosphate-buffered saline (PBS) supplemented
with 2% bovine serum albumin (BSA) for counting on an
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automated cell before direct cell surface staining. For intracellular
staining, cells were fixed and permeabilized with a commercially
available fixation/permeabilization kit (eBioscience). Single-cell
suspensions were stained with antibodies to the following
markers: CD45-BV421, CD3-APC/Fire750, CD4-FITC, CD25-
BV510, CD8a-BV711, CD335-PECy7, CD19-BV605, CD11b-
PERcpCY5.5, RORγt-APC, and Foxp3-PE in presence of
FCBlock CD16/32; all antibodies were obtained from Biolegend.
The gating strategy is detailed in Supplementary Figure 8.
Gallios cytometer (Beckman) was used for cell acquisition, and
the flow cytometry data were analyzed with Kaluza software.
Cytokine Bead Assay
Total protein was extracted from colonic tissue by lysing
homogenized tissue with Bio-plex Cell lysis kit (Bio-rad
#171304011, Bio-Rad Laboratories Inc, USA) and quantified by
using the bicinchoninic acid assay method. All samples were
normalized to 900µg/mL for the assay. Cytokine levels in plasma
and colonic lysates were measured using Bio-Plex Pro mouse
cytokines 23-plex assay group I assay (Bio-Rad #M60009RDPD,
Bio-Rad Laboratories Inc, USA), a BioPlex 200 instrument,
and Milliplex Analyst software. Each biological replicate was
assayed in technical duplicate. According to the manufacturer’s
instructions, protein concentrations were determined based on a
standard curve described by the manufacturer-provided protocol
and values for Lot #64212941.
RNA Extraction and Microarray Experiment
Total RNA was extracted from 20mg of colon sample using
Trizol (Invitrogen, Carlsbad, California, USA) according to the
manufacturer’s recommendations. RNA was further digested
with TurboTMDNase (Thermo Fisher, Waltham,Massachusetts,
USA) and phenol-chloroform extracted. The quality of total
RNAs was attested by O.D. 260 nm/O.D. 280 nm and O.D.
260 nm/O.D. 230 nm determination by spectrophotometry using
a Nanodrop ND-1000 (NanoDrop Technologies; Wilmington,
DE, USA) and using a 2,100 Bioanalyzer (Agilent Technologies;
Massy, France). Samples with RNA integrity number > 8
were selected. RNA samples were aliquoted and stored at
−80 ◦C, and later amplified and biotinylated using the
Affymetrix GeneChip R© WT PLUS reagent kit, then hybridized
to Affymetrix Mouse Clariom S cartridges following the
manufacturer’s instructions. The arrays were washed and
scanned according to the protocol GeneChip R© Expression
Wash, Stain and Scan for Cartridge Arrays.
Transcriptomics
Fluorescence values corresponding to raw expression data for
every 37 samples were extracted from CEL files using the R oligo
package (https://bioconductor.org/) with the corresponding
platform definitions (pd.clariom.s.mouse). Positive and negative
control probes were removed, which left 21.881 probes, each
corresponding to a unique and well-annotated gene. Quality
control steps, data normalization, and unsupervised explorations
were conducted as described previously (62). Corrections
for batch effects between microarrays were performed with
Combat (package sva from Bioconductor). Statistical analyses
were achieved using linear modeling with empirical Bayes,
p.values were computed by applying a moderated two-way
t-test and adjusted for false discovery rate (FDR) following
the Benjamini–Hochberg procedure. Hierarchical clustering
heat maps were obtained on gene-median-centered data with
uncentered correlation as a similarity metric. Volcano plots were
rendered using EnhancedVolcano (Bioconductor). Functional
annotations were performed with the OpenTargets platform
(63) for disease associations and gene ontology enrichments
and ReactomePA (64) for pathway analyses in mice. For all
experiments, p.values < 0.001 or FDR < 0.05 indicated statistical
significance, depending on the test availability and/or relevance.
Microbiota Analysis
Bacterial profiling using 16S amplicon sequencing was performed
as described previously (65). Briefly, DNA from fecal pellets
was isolated using the PowerSoil DNA Isolation Kit (MoBio)
according to the manufacturer’s directions. Individual amplicons
were tagged with specific multiplex identifier (MID) barcodes
and pooled for library construction before sequencing. The 16S
rRNA gene variable region V3-V4 was amplified and sequenced
on an Illumina MiSeq with 2 × 250 bp. Raw sequences were first
trimmed to remove bad quality tails and filtered for size using
CUTADAPT (66) v1.1.4. Then USEARCH (67, 68) v10.0.240 was
used to merge forward and reverse reads. Merged reads were
filtered for size and expected error rate before dereplication and
denoising, simultaneously removing chimeras. Reads present in
less than two copies were filtered out as they likely represent PCR
or sequencing errors. A custom R (69) script was used to transfer
sequences into MOTHUR (70) v1.39.5, with which further
processing was done according to the MiSeq SOP (71). Briefly,
sequences were aligned to the SILVA (72) v132 reference database,
classified against the RDP release 11 (trainset 16) (73) database,
binned into operational taxonomic units (OTUs) at the species-
level 97% identity threshold, and rarefied to 12,000 sequences
per sample. A detailed account of the procedure is available
in Supplementary Dataset 2. This procedure filtered 4 763 346
sequences for 147 samples, and lead 3 152 719 sequenced to be
retained (66%) before subsampling (Supplementary Dataset 3).
Additional formatting scripts are available in Dataset S4. The
OTU Table obtained from MOTHUR was imported in R (69) for
statistical analysis. Alpha diversity indices (Chao and Shannon)
were calculated with vegan (74) package version 2.5–6. Fold
changes between time points were calculated as: log2 (target
value/reference value). Correlations between α-diversity indices
or fold change and experimental parameters were tested using
the Wilcoxon rank sum test. Beta diversity was evaluated with
the vegan (74) package version 2.5–6, using the Bray-Curtis and
Jaccard distances to build principal coordinate analysis (PCoA).
Fold changes of OTU abundances between time points were
calculated as: log2 [(target value+0.1)/ (reference value+0.1)].
The addition of 0.1 to both values avoids infinite values due to
zero abundances, while keeping the ratios in the same trend.
Correlations with experimental parameters were assessed with
multivariate analysis of variance using package pairwiseAdonis
(75). Biomarkers were found by correlating individual OTUs
with experimental parameters with four complementary tests:
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Kruskal-Wallis rank sum test was done on OTU abundances and
fold changes (i) or non-zero OTU abundances (ii); Pearson’s chi-
square test was performed on OTU prevalence (iii); indicator
species analysis (iv) was conducted with package indicspecies (76).
To evaluate the strength of association, Eta was calculated for
Kruskal-Wallis tests and Cramer’s V for chi-square tests. Where
applicable, p-values were adjusted for multiple testing using the
false discovery rate (“FDR”) correction. All necessary data and
scripts for analysis are available in Supplementary Dataset 5.
Evaluation of the Fermentative Activity of
the Microbiota
The concentrations of short-chain fattyacids (SCFAs; i.e.
acetate, propionate, butyrate, valerate, caproate, isobutyrate,
isovalerate, and isocaproate) were measured in the cecal
contents and stool samples of mice. Analyses were performed
as previously described (77). Samples were water-extracted,
and proteins were precipitated with phosphotungstic acid.
Analyzes were performed by gas chromatography using a
system (Autosystem; Perkin-Elmer, St. Quentin en Yvelines,
France) equipped with a split/splitless injector, a flame
ionization detector, and a capillary column (length, 15m;
inside diameter, 0.53mm; film thickness, 0.5m) impregnated
with SP100 (Nukol; Supelco, Saint-Quentin-Fallavier, France).
The internal standard used was 2-ethylbutyrate. All samples
were analyzed in duplicate. Data were collected, and peaks
were integrated using Turbochrom software (Perkin-Elmer,
Courtaboeuf, France).
Statistical Analysis
All data are expressed as means± SEM. Two-group comparisons
were performed using Mann-Whitney U-test for non-parametric
data or t-test for parametric data. ANOVA with Tukey’s post-
hoc test for parametric data or Kruskal Wallis with Dunn’s
correction for non-parametric data were used to compare more
than two groups. p values < 0.05 were considered significant.
Statistical details and the exact value of “N” can be found in
the Figure legends. Statistical analyses were performed with
GraphPad Prism 6 software (GraphPad Software, Inc, La Jolla,
CA). All authors had access to the all data and have reviewed and
approved the final manuscript.
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